Aspecthera Pty Ltd
PrivateLast Round
Accelerator
Jun 26, 2025
Total Funding Raised
$450,000
Company Overview
Aspecthera Pty Ltd is a pharmaceutical company developing a non-invasive eye-drop therapy for the treatment of early-stage diabetic retinopathy.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Aspecthera Pty Ltd Comparables
Compare Aspecthera Pty Ltd with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| D-Sight | 86% | |
| Exonate | 77% | |
| SmartinBio Co., Ltd. | 75% | |
Aspecthera Pty Ltd Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Jun 26, 2025 |
Aspecthera Pty Ltd Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| MTPConnect | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 26, 2025
$450K raised from health-gov and MTPConnect.
Aspecthera Pty Ltd Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Aspecthera Pty Ltd's valuation, stock price, and market status.